The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group.
Wilczek
H E
HE
Dept of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
Berglin
E
E
Blohmé
I
I
Bäckman
L
L
Fehrman
I
I
Källen
R
R
Nyberg
G
G
Säwe
J
J
Wahlberg
J
J
D000284:Administration, Oral; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004304:Dosage Forms; D016027:Heart Transplantation / Q000276:immunology; D016041:Heart-Lung Transplantation / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology; D016035:Pancreas Transplantation / Q000276:immunology; D013548:Sweden
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine